Martin Caitlin E, Longinaker Nyaradzo, Mark Katrina, Chisolm Margaret S, Terplan Mishka
From the Department of Obstetrics and Gynecology (CEM), University of North Carolina Hospitals, Chapel Hill, NC; Department of Epidemiology and Public Health (NL, MT), University of Maryland, Baltimore, MD; Department Obstetrics, Gynecology and Reproductive Sciences (KM), University of Maryland School of Medicine, Baltimore, MD; Department of Psychiatry and Behavioral Sciences (MSC), Johns Hopkins University School of Medicine, Baltimore, MD; and Behavioral Health System Baltimore (MT), Baltimore, MD.
J Addict Med. 2015 Mar-Apr;9(2):99-104. doi: 10.1097/ADM.0000000000000095.
The objective of this study was to investigate recent trends in substance abuse treatment admissions for marijuana use during pregnancy in the United States.
Data were obtained from the Treatment Episodes Data Set from 1992 to 2012 and analyzed for trends over time using χ, Cochran-Armitage, and Moran's I tests.
The proportion of treatment admissions for women who were pregnant remained stable at 4%; however, admissions of pregnant women reporting any marijuana use increased substantially from 29% to 43% (P < 0.01). The West North Central census division (20%) experienced the greatest increase followed by the Middle Atlantic (18%) and Pacific (14%) divisions. The demographic characteristics of pregnant marijuana admissions changed over time, with white non-Hispanic women, criminal justice referrals, and those with a psychiatric comorbidity becoming more common whereas polysubstance users decreased (P < 0.01).
Even though more women using marijuana are seeking and receiving substance abuse treatment during pregnancy, targeting certain risk groups while improving screening and treatment referral systems by health care providers, such as prenatal caregivers, should be emphasized.
本研究的目的是调查美国孕期因使用大麻而接受药物滥用治疗的近期趋势。
数据取自1992年至2012年的治疗事件数据集,并使用χ检验、 Cochr an-Armitage检验和Moran's I检验分析随时间的趋势。
孕期女性接受治疗的比例稳定在4%;然而,报告使用过大麻的孕妇的治疗入院率从29%大幅增至43%(P<0.01)。西中北部人口普查区(20%)增长幅度最大,其次是大西洋中部(18%)和太平洋(14%)地区。孕期大麻使用者的人口统计学特征随时间变化,非西班牙裔白人女性、刑事司法转诊患者以及患有精神疾病合并症的患者更为常见,而使用多种药物的患者减少(P<0.01)。
尽管越来越多使用大麻的女性在孕期寻求并接受药物滥用治疗,但仍应强调针对某些风险群体,同时改善医疗保健提供者(如产前护理人员)的筛查和治疗转诊系统。